Results 21 to 30 of about 395,113 (303)

Genomic tumor studies aid in diagnosing metastatic basal cell carcinoma: A case series [PDF]

JAAD Case Reports, 2021
Kylee J.B. Kus, BS, Emily S. Ruiz, MD, MPH   +1 more
doaj   +2 more sources

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. [PDF]

JAMA Dermatol, 2016
Ally MS, Ransohoff K, Sarin K, Atwood SX, Rezaee M, Bailey-Healy I, Kim J, Beachy PA, Chang AL, Oro A, Tang JY, Colevas AD.   +11 more
europepmc   +2 more sources

Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins [PDF]

JAAD Case Reports, 2017
Nathan M. Johnson, MS, Alex C. Holliday, MD, David T. Luyimbazi, MD, Mariana A. Phillips, MD, George R. Collins, DO, Douglas J. Grider, MD   +5 more
doaj   +2 more sources

Metastatic basal cell carcinoma. Report of five cases

Cancer, 1994
S. Snow, W. Sahl, J. Lo, F. Mohs, Thomas F. C. S. Warner, Jack A. Dekkinga, J. Feyzi   +6 more
exaly   +2 more sources

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors.

Annals of Oncology, 2023
BACKGROUND Metastatic basal cell carcinoma (mBCC) is a rare condition with no effective second-line treatment options. Cemiplimab is an immune checkpoint inhibitor that blocks binding of programmed cell death-1 (PD-1) to its ligands, PD-L1 and PD-L2 ...
K. D. Lewis, K. Peris, A. Sekulic, A. Stratigos, L. Dunn, Z. Eroglu, A. Chang, M. Migden, Suk-Young Yoo, K. Mohan, E. Coates, E. Okoye, T. Bowler, J. Baurain, O. Bechter, A. Hauschild, M.O. Butler, L. Hernandez-Aya, L. Licitra, R. Neves, E.S. Ruiz, F. Seebach, I. Lowy, P. Goncalves, M. Fury   +24 more
semanticscholar   +1 more source

Metastatic basal cell carcinoma caused by carcinoma misdiagnosed as acne – case report and literature review [PDF]

Clinical Case Reports (discontinued), 2016
Lisbet R Hölmich
exaly   +2 more sources

Metastatic basal cell carcinoma exhibits reduced actin expression

Modern Pathology, 2008
Alexander J F Lazar
exaly   +2 more sources

Basal Cell Carcinoma with Disseminated Bone Metastization: An Unusual Outcome of the Most Common Malignancy

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Basal cell carcinoma is the most common skin cancer, with a very low incidence of metastases, associated with high morbidity and mortality. The morpheaform clinical variant is uncommon, presenting an aggressive growth pattern.
Luísa Rolim, Bruno M. Fernandes, Carolina Carvalho, António Silva, Joana Calvão, Ricardo Vieira, Margarida Borrego   +6 more
doaj   +1 more source

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report

Journal of Medical Case Reports, 2022
Background The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma.
Zsófia Küronya, Tímea Danyi, Tímea Balatoni, Gabriella Liszkay, Erika Tóth, Krisztina Biró, Lajos Géczi   +6 more
doaj   +1 more source

Histology of non-melanoma skin cancers. An Update [PDF]

, 2017
Non-melanoma skin cancer (NMSC) is the most frequently diagnosed cancer in humans. Several different non-melanoma skin cancers have been reported in the literature, with several histologic variants that frequently cause important differential diagnoses ...
Cantisani, Carmen, Didona, Dario, Donati, Michele, Mercuri, Santo Raffaele, Paolino, Giovanni   +4 more
core   +2 more sources